Progress in Neuro-Psychopharmacology and Biological Psychiatry

6.7k papers and 208.4k indexed citations i.

About

The 6.7k papers published in Progress in Neuro-Psychopharmacology and Biological Psychiatry in the last decades have received a total of 208.4k indexed citations. Papers published in Progress in Neuro-Psychopharmacology and Biological Psychiatry usually cover Cellular and Molecular Neuroscience (2.3k papers), Psychiatry and Mental health (1.8k papers) and Cognitive Neuroscience (1.6k papers) specifically the topics of Neurotransmitter Receptor Influence on Behavior (1.2k papers), Neuroscience and Neuropharmacology Research (1.1k papers) and Tryptophan and brain disorders (919 papers). The most active scholars publishing in Progress in Neuro-Psychopharmacology and Biological Psychiatry are Michaël Maes, Yong‐Ku Kim, Brian E. Leonard, Ingmar H. A. Franken, Franco Benazzi, John Hyttel, Alistair J. Barber, Michael Berk, Abdalla Elhwuegi and Piotr Gałecki.

In The Last Decade

Fields of papers published in Progress in Neuro-Psychopharmacology and Biological Psychiatry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Progress in Neuro-Psychopharmacology and Biological Psychiatry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Countries where authors publish in Progress in Neuro-Psychopharmacology and Biological Psychiatry

Since Specialization
Citations

This map shows the geographic impact of research published in Progress in Neuro-Psychopharmacology and Biological Psychiatry. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Progress in Neuro-Psychopharmacology and Biological Psychiatry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Progress in Neuro-Psychopharmacology and Biological Psychiatry more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025